FDA Inspection 1277157 — Rhode Island Blood Center, A Division of New York Blood Center, Inc.
The FDA completed an inspection of Rhode Island Blood Center, A Division of New York Blood Center, Inc. on August 1, 2025 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 1, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Providence, RI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 160 | 21 CFR 606.160(a)(1) | Person performing, test results, interpretation |
| 63 | 21 CFR 606.65 | Safe, sanitary, orderly storage |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |